Figure 3From: Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemiaRelative plasma miR-150 and miR-342 expression levels normalized by cel-miR-39 and hsa-miR-16. MiR-150 (A, B) and miR-342 (C, D) expression levels were assessed by qRT-PCR and normalized by cel-miR-39 and hsa-miR-16 respectively in healthy controls and Acute Myeloid Leukemia patients. Shown are the relative levels (mean ± S.D.) of five independent experiments performed on all participants, each done in triplicate. Statistical significance was determined by Student’s t test and is denoted as follows: ** p < 0.01 versus healthy donors.Back to article page